These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10976784)

  • 1. Endothelin in cardiovascular disease: from atherosclerosis to heart failure.
    Best PJ; Lerman A
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S61-63. PubMed ID: 10976784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin and endothelin receptor antagonists in heart failure.
    Greenberg BH
    Congest Heart Fail; 2002; 8(5):257-61. PubMed ID: 12368588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insight into coronary endothelial dysfunction: role of endothelin.
    Cannan CR; Mathew V; Lerman A
    J Lab Clin Med; 1998 Apr; 131(4):300-5. PubMed ID: 9579382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of endothelin as a vasoconstrictor substance in congestive heart failure.
    Cody RJ
    Eur Heart J; 1992 Nov; 13(11):1573-8. PubMed ID: 1464346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endothelin in cardiovascular disease.
    Agapitov AV; Haynes WG
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):1-15. PubMed ID: 11984741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endothelin--a cardiovascular regulatory peptide. II. Outline of its pathophysiologic activity].
    Lisý O
    Cesk Fysiol; 1995 Sep; 44(3):152-7. PubMed ID: 7586020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling.
    Kirchengast M; Münter K
    Proc Soc Exp Biol Med; 1999 Sep; 221(4):312-25. PubMed ID: 10460693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders.
    Spieker LE; Noll G; Lüscher TF
    Am J Cardiovasc Drugs; 2001; 1(4):293-303. PubMed ID: 14728028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
    Spieker LE; Noll G; Ruschitzka FT; Lüscher TF
    J Am Coll Cardiol; 2001 May; 37(6):1493-505. PubMed ID: 11345356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin in atherosclerosis: importance of risk factors and therapeutic implications.
    d'Uscio LV; Barton M; Shaw S; Lüscher TF
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S55-59. PubMed ID: 10976783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endothelin system as target for therapeutic interventions in cardiovascular and renal disease.
    Eroglu E; Kocyigit I; Lindholm B
    Clin Chim Acta; 2020 Jul; 506():92-106. PubMed ID: 32151622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endothelin--a cardiovascular regulatory peptide. I. Physiologic activity].
    Lisý O
    Cesk Fysiol; 1995 Sep; 44(3):147-51. PubMed ID: 7586019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.
    Kiowski W; Sütsch G; Hunziker P; Müller P; Kim J; Oechslin E; Schmitt R; Jones R; Bertel O
    Lancet; 1995 Sep; 346(8977):732-6. PubMed ID: 7658874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin and endothelin receptor antagonism in heart failure.
    Sütsch G; Kiowski W
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S69-73. PubMed ID: 10976786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin and heart failure.
    Nambi P; Clozel M; Feuerstein G
    Heart Fail Rev; 2001 Dec; 6(4):335-40. PubMed ID: 11447308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Endothelin antagonism in heart failure.
    Webb DJ
    Circulation; 1995 Dec; 92(12):3372. PubMed ID: 8521551
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical potential of endothelin receptor antagonists in cardiovascular medicine.
    Ferro CJ; Webb DJ
    Drugs; 1996 Jan; 51(1):12-27. PubMed ID: 8741230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin receptor antagonists. Promising new agents in the management of cardiovascular disorders.
    Goddard J; Webb DJ
    Drugs R D; 1999 Jul; 2(1):1-12. PubMed ID: 10560541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of endothelins and their receptors in heart failure.
    Giannessi D; Del Ry S; Vitale RL
    Pharmacol Res; 2001 Feb; 43(2):111-26. PubMed ID: 11243712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelins and anti-endothelins.
    Bhatt AD
    J Assoc Physicians India; 1997 Nov; 45(11):868-72. PubMed ID: 11229190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.